Simplex Trading
VERV

Simplex Trading’s Verve Therapeutics VERV Stock Holding History

Simplex Trading’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-432,800
Closed -$4.86M – 10159
2025
Q2 		$4.86M Buy
432,800
+432,500
+144,167% +$2.47M ﹤0.01% 1362
2025
Q1 		$1K Sell
300
-800
-73% -$5.36K ﹤0.01% 8328
2024
Q4 		$6K Sell
1,100
-32,600
-97% -$184K ﹤0.01% 7551
2024
Q3 		$163K Sell
33,700
-15,100
-31% -$87.7K ﹤0.01% 4724
2024
Q2 		$238K Buy
48,800
+5,500
+13% +$34.6K ﹤0.01% 4495
2024
Q1 		$575K Sell
43,300
-8,100
-16% -$107K ﹤0.01% 3717
2023
Q4 		$716K Buy
51,400
+50,700
+7,243% +$628K ﹤0.01% 3349
2023
Q3 		$9K Hold
700
– – ﹤0.01% 7278
2023
Q2 		$13K Buy
+700
New +$11.7K ﹤0.01% 7197
2023
Q1 		– Sell
-1,000
Closed -$19K – 10215
2022
Q4 		$19K Sell
1,000
-100
-9% -$2.65K ﹤0.01% 6937
2022
Q3 		$37K Buy
1,100
+100
+10% +$3.19K ﹤0.01% 6828
2022
Q2 		$15K Sell
1,000
-13,800
-93% -$214K ﹤0.01% 7900
2022
Q1 		$337K Buy
14,800
+14,500
+4,833% +$414K ﹤0.01% 4377
2021
Q4 		$11K Buy
+300
New +$12.6K ﹤0.01% 8964

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplex Trading's VERV Position: Q3 2025 in Review

Simplex Trading sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 81,129 shares — an estimated $911K sold.

Simplex Trading first reported a position in VERV in Q4 2021 and held it in 10 quarters. The position peaked at $911K in Q2 2025. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Simplex Trading reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 81,129 Verve Therapeutics shares in Q3 2025, an estimated $911K.
  • Simplex Trading first reported a position in Verve Therapeutics in Q4 2021 and held it in 10 quarters.
  • Simplex Trading's Verve Therapeutics position peaked at $911K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.